- Citations, last 5 years
- 570
- Works, last 5 years
- 54
- h-index
- 21
- Scientists listed
- 11
- Grants since 2016
- 4
Grants received
2020–2022 · research · R41
Advancing Small Molecule Read Through Compounds to Prevent and/or Treat Heritable Pulmonary Artery Hypertension
Virender K Rehan · Accent Therapeutics (United States) · funded by National Institutes of Health
2018–2026 · research · R44
Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation
Craig Gelfand · Accent Therapeutics (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia
Craig Gelfand · Accent Therapeutics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury
Craig Gelfand · Accent Therapeutics (United States) · funded by National Institutes of Health
